Pregnancy and Neonatal Outcomes in SARS-CoV-2 Infection: A Systematic Review

• Published in: Journal of pregnancy 2020-10, Vol.2020 (2020), p.1-7
• Main Authors: Ahmed, Baderledeen, Salomon, Laurent J., Chervenak, Frank, Wahbeh, Farah, Chamseddine, Reem S., Rafii, Arash
• Format: Article
• Language: English
• Subjects: Antiviral agents; Antiviral drugs; Asymptomatic; Betacoronavirus; Cardiac arrhythmia; Care and treatment; Cesarean section; Consolidation; Coronavirus Infections - diagnosis; Coronavirus Infections - epidemiology; Coronavirus Infections - therapy; Coronaviruses; Cough; COVID-19; Diabetes; Diagnosis; Dosage and administration; Dyspnea; Female; Fever; Health aspects; Humans; Infant, Newborn; Infections; Influenza; Laboratories; Middle East respiratory syndrome; Miscarriage; Mortality; Mothers; Neonates; Newborn babies; Obstetrics; Oxygen saturation; Pandemics; Patient outcomes; Patients; Pneumonia; Pneumonia, Viral - diagnosis; Pneumonia, Viral - epidemiology; Pneumonia, Viral - therapy; Pregnancy; Pregnancy complications; Pregnancy Complications, Infectious - diagnosis; Pregnancy Complications, Infectious - epidemiology; Pregnancy Complications, Infectious - therapy; Pregnancy Outcome; Pregnancy, Complications of; Pregnant women; Premature birth; Respiration; Respiratory diseases; Respiratory syncytial virus; Review; SARS-CoV-2; Severe acute respiratory syndrome coronavirus 2; Systematic review; Ultrasonic imaging; Viral infections; Womens health
• ISSN: 2090-2727; 2090-2735; 2090-2735
• DOI: 10.1155/2020/4592450

With the emergence of SARS-CoV-2 and its rapid spread, concerns regarding its effects on pregnancy outcomes have been growing. We reviewed 245 pregnancies complicated by maternal SARS-CoV-2 infection across 48 studies listed on PubMed and MedRxiv. The most common clinical presentations were fever (55.9%), cough (36.3%), fatigue (11.4%), and dyspnea (12.7%). Only 4.1% of patients developed respiratory distress. Of all patients, 89.0% delivered via cesarean section (n=201), with a 33.3% rate of gestational complications, a 35.3% rate of preterm delivery, and a concerning 2.5% rate of stillbirth delivery or neonatal death. Among those tested, 6.45% of newborns were reported positive for SARS-CoV-2 infection. Relative to known viral infections, the prognosis for pregnant women with SARS-CoV-2 is good, even in the absence of specific antiviral treatment. However, neonates and acute patients, especially those with gestational or preexisting comorbidities, must be actively managed to prevent the severe outcomes being increasingly reported in the literature.